These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7189413)

  • 1. The anti-heparin properties of human low-density lipoprotein.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1980 Mar; 617(3):472-9. PubMed ID: 7189413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of anti-Xa activity in human plasma. II: The role of lipoproteins.
    Barrowcliffe TW; Eggleton CA; Stocks J
    Thromb Res; 1982 Jul; 27(2):185-95. PubMed ID: 7135353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoproteins enhance tissue factor-independent factor VII activation.
    Kjalke M; Silveira A; Hamsten A; Hedner U; Ezban M
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1835-41. PubMed ID: 10894826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human factor Xa by various plasma protease inhibitors.
    Ellis V; Scully M; MacGregor I; Kakkar V
    Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.
    Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA
    Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
    Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
    Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralisation of heparan sulphate and low molecular weight heparin by protamine.
    Hubbard AR; Jennings CA
    Thromb Haemost; 1985 Feb; 53(1):86-9. PubMed ID: 3158095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids.
    Lewis TV; Dart AM; Chin-Dusting JP
    Cardiovasc Res; 1997 Jun; 34(3):590-6. PubMed ID: 9231043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoproteins modulate growth and differentiation of cultured human epidermal keratinocytes.
    Furumoto H; Arai H; Kuramitsu Y; Saeki Y; Gondo T; Ishihara T; Shimizu T; Fujimoto M; Nakamura K
    Electrophoresis; 2002 Jan; 23(2):161-6. PubMed ID: 11840518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enzymatic glycosylation of plasma lipoproteins in vitro.
    Smith CC; Dickson AC; Betteridge DJ
    Diabetes Res; 1985 Nov; 2(6):277-82. PubMed ID: 4075697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
    Hubbard AR; Jennings CA
    Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractions.
    Walenga JM; Bara L; Samama MM; Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):100-7. PubMed ID: 4035361
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR; Lie M; Abildgaard U
    Haemostasis; 1976; 5(5):265-75. PubMed ID: 1017722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential binding of chlordecone to the protein and high density lipoprotein fractions of plasma from humans and other species.
    Soine PJ; Blanke RV; Guzelian PS; Schwartz CC
    J Toxicol Environ Health; 1982 Jan; 9(1):107-18. PubMed ID: 6174734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone production by cultured luteal cells in the presence of bovine low- and high-density lipoproteins purified by heparin affinity chromatography.
    Carroll DJ; Grummer RR; Mao FC
    J Anim Sci; 1992 Aug; 70(8):2516-26. PubMed ID: 1506313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.